These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 35442721)

  • 1. Common Variant in ALDH2 Modifies the Risk of Breast Cancer Among Carriers of the p.K3326* Variant in BRCA2.
    Kluźniak W; Szymiczek A; Rodrigue A; Wokołorczyk D; Rusak B; Stempa K; Huzarski T; Gronwald J; Lubiński J; Zamani N; Zhang S; Masson JY; Narod SA; ; Cybulski C; Akbari MR
    JCO Precis Oncol; 2022 Apr; 6():e2100450. PubMed ID: 35442721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Single nucleotide polymorphism in the ALDH2 gene modifies the risk of esophageal squamous cell carcinoma in BRCA2 p.K3326* carriers.
    Zamani N; Szymiczek A; Shakeri R; Poustchi H; Pourshams A; Narod S; Malekzadeh R; Akbari MR
    PLoS One; 2023; 18(11):e0292611. PubMed ID: 37943872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of BRCA2 K3326* With Small Cell Lung Cancer and Squamous Cell Cancer of the Skin.
    Rafnar T; Sigurjonsdottir GR; Stacey SN; Halldorsson G; Sulem P; Pardo LM; Helgason H; Sigurdsson ST; Gudjonsson T; Tryggvadottir L; Olafsdottir GH; Jonasson JG; Alexiusdottir K; Sigurdsson A; Gudmundsson J; Saemundsdottir J; Sigurdsson JK; Johannsdottir H; Uitterlinden A; Vermeulen SH; Galesloot TE; Allain DC; Lacko M; Sigurgeirsson B; Thorisdottir K; Johannsson OT; Sigurdsson F; Ragnarsson GB; Isaksson H; Hardardottir H; Gudbjartsson T; Gudbjartsson DF; Masson G; Kiemeney LAML; Ewart Toland A; Nijsten T; Peters WHM; Olafsson JH; Jonsson S; Thorsteinsdottir U; Thorleifsson G; Stefansson K
    J Natl Cancer Inst; 2018 Sep; 110(9):967-974. PubMed ID: 29767749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of impact of the ALDH2 rs671 variant on breast cancer development in Japanese BRCA1/2-mutation carriers.
    Mori T; Okamoto Y; Mu A; Ide Y; Yoshimura A; Senda N; Inagaki-Kawata Y; Kawashima M; Kitao H; Tokunaga E; Miyoshi Y; Ohsumi S; Tsugawa K; Ohta T; Katagiri T; Ohtsuru S; Koike K; Ogawa S; Toi M; Iwata H; Nakamura S; Matsuo K; Takata M
    Cancer Med; 2023 Mar; 12(6):6594-6602. PubMed ID: 36345163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common genetic variants and modification of penetrance of BRCA2-associated breast cancer.
    Gaudet MM; Kirchhoff T; Green T; Vijai J; Korn JM; Guiducci C; Segrè AV; McGee K; McGuffog L; Kartsonaki C; Morrison J; Healey S; Sinilnikova OM; Stoppa-Lyonnet D; Mazoyer S; Gauthier-Villars M; Sobol H; Longy M; Frenay M; GEMO Study Collaborators ; Hogervorst FB; Rookus MA; Collée JM; Hoogerbrugge N; van Roozendaal KE; ; Piedmonte M; Rubinstein W; Nerenstone S; Van Le L; Blank SV; Caldés T; de la Hoya M; Nevanlinna H; Aittomäki K; Lazaro C; Blanco I; Arason A; Johannsson OT; Barkardottir RB; Devilee P; Olopade OI; Neuhausen SL; Wang X; Fredericksen ZS; Peterlongo P; Manoukian S; Barile M; Viel A; Radice P; Phelan CM; Narod S; Rennert G; Lejbkowicz F; Flugelman A; Andrulis IL; Glendon G; Ozcelik H; ; Toland AE; Montagna M; D'Andrea E; Friedman E; Laitman Y; Borg A; Beattie M; Ramus SJ; Domchek SM; Nathanson KL; Rebbeck T; Spurdle AB; Chen X; Holland H; ; John EM; Hopper JL; Buys SS; Daly MB; Southey MC; Terry MB; Tung N; Overeem Hansen TV; Nielsen FC; Greene MH; Mai PL; Osorio A; Durán M; Andres R; Benítez J; Weitzel JN; Garber J; Hamann U; ; Peock S; Cook M; Oliver C; Frost D; Platte R; Evans DG; Lalloo F; Eeles R; Izatt L; Walker L; Eason J; Barwell J; Godwin AK; Schmutzler RK; Wappenschmidt B; Engert S; Arnold N; Gadzicki D; Dean M; Gold B; Klein RJ; Couch FJ; Chenevix-Trench G; Easton DF; Daly MJ; Antoniou AC; Altshuler DM; Offit K
    PLoS Genet; 2010 Oct; 6(10):e1001183. PubMed ID: 21060860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A common missense variant in BRCA2 predisposes to early onset breast cancer.
    Górski B; Narod SA; Lubinski J
    Breast Cancer Res; 2005; 7(6):R1023-7. PubMed ID: 16280055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants in ALDH2 predict risk of ischemic stroke in a Chinese population.
    Cheng X; Xu J; Gu M; Wang M; Sun B; Li Z; Ni G; Wang G; Weng Z; Shi Y; Zhang Z; Liu X
    Gene; 2018 Dec; 678():49-54. PubMed ID: 30077765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of the variant allele rs61764370 T>G in the 3'UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer families.
    Hollestelle A; Pelletier C; Hooning M; Crepin E; Schutte M; Look M; Collee JM; Nieuwlaat A; Dorssers LC; Seynaeve C; Aulchenko YS; Martens JW; van den Ouweland AM; Weidhaas JB
    Breast Cancer Res Treat; 2011 Jul; 128(1):79-84. PubMed ID: 20676756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reevaluation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer context.
    Thompson ER; Gorringe KL; Rowley SM; Li N; McInerny S; Wong-Brown MW; Devereux L; Li J; ; Trainer AH; Mitchell G; Scott RJ; James PA; Campbell IG
    Sci Rep; 2015 Oct; 5():14800. PubMed ID: 26455428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the common polymorphism in the human aldehyde dehydrogenase 2 (ALDH2) gene on the lung.
    Kuroda A; Hegab AE; Jingtao G; Yamashita S; Hizawa N; Sakamoto T; Yamada H; Suzuki S; Ishii M; Namkoong H; Asakura T; Ozaki M; Yasuda H; Hamamoto J; Kagawa S; Soejima K; Betsuyaku T
    Respir Res; 2017 Apr; 18(1):69. PubMed ID: 28431562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The RAD52 S346X variant reduces risk of developing breast cancer in carriers of pathogenic germline BRCA2 mutations.
    Adamson AW; Ding YC; Mendez-Dorantes C; Bailis AM; Stark JM; Neuhausen SL
    Mol Oncol; 2020 Jun; 14(6):1124-1133. PubMed ID: 32175645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer risk associated with BRCA1/2 variants in the Pakistani population.
    Abbas S; Siddique A; Shahid N; Khan RT; Fatima W
    Breast Cancer; 2019 May; 26(3):365-372. PubMed ID: 30430339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Aldehyde Dehydrogenase ALDH2*2 Allele, Associated with Alcohol Drinking Behavior, Dates Back to Prehistoric Times.
    Lin CL; Chien RN; Chen LW; Huang TS; Shyu YC; Yeh CT; Liang KH
    Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The BARD1 Cys557Ser variant and breast cancer risk in Iceland.
    Stacey SN; Sulem P; Johannsson OT; Helgason A; Gudmundsson J; Kostic JP; Kristjansson K; Jonsdottir T; Sigurdsson H; Hrafnkelsson J; Johannsson J; Sveinsson T; Myrdal G; Grimsson HN; Bergthorsson JT; Amundadottir LT; Gulcher JR; Thorsteinsdottir U; Kong A; Stefansson K
    PLoS Med; 2006 Jul; 3(7):e217. PubMed ID: 16768547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel and recurrent BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer: a series from the south of Tunisia.
    Ben Ayed-Guerfali D; Ben Kridis-Rejab W; Ammous-Boukhris N; Ayadi W; Charfi S; Khanfir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
    J Transl Med; 2021 Mar; 19(1):108. PubMed ID: 33726785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible association of the BRCA2 gene C5972T variant with gastric cancer: a study on Polish population.
    Ławniczak M; Jakubowska A; Białek A; Karpińska-Kaczmarczyk K; Lubiński J; Starzyńska T
    Pol Arch Med Wewn; 2015; 125(1-2):39-45. PubMed ID: 25533971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers.
    Kadouri L; Kote-Jarai Z; Hubert A; Durocher F; Abeliovich D; Glaser B; Hamburger T; Eeles RA; Peretz T
    Br J Cancer; 2004 May; 90(10):2002-5. PubMed ID: 15138485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent.
    Yarden RI; Friedman E; Metsuyanim S; Olender T; Ben-Asher E; Papa MZ
    Breast Cancer Res Treat; 2008 Oct; 111(3):497-504. PubMed ID: 18026875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers.
    Maia AT; Antoniou AC; O'Reilly M; Samarajiwa S; Dunning M; Kartsonaki C; Chin SF; Curtis CN; McGuffog L; Domchek SM; ; Easton DF; Peock S; Frost D; Evans DG; Eeles R; Izatt L; Adlard J; Eccles D; ; Sinilnikova OM; Mazoyer S; Stoppa-Lyonnet D; Gauthier-Villars M; Faivre L; Venat-Bouvet L; Delnatte C; Nevanlinna H; Couch FJ; Godwin AK; Caligo MA; ; Barkardottir RB; ; Chen X; Beesley J; Healey S; Caldas C; Chenevix-Trench G; Ponder BA
    Breast Cancer Res; 2012 Apr; 14(2):R63. PubMed ID: 22513257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldehyde dehydrogenase 2 polymorphism is associated with chemotherapy-related cognitive impairment in patients with breast cancer who receive chemotherapy.
    Yao S; Li W; Liu S; Cai Y; Zhang Q; Tang L; Yu S; Jing Y; Yin X; Cheng H
    Cancer Med; 2023 Mar; 12(5):5209-5221. PubMed ID: 36200595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.